Intracerebroventricular and intraperitoneal disodium phosphonoacetate treatment of herpes simplex virus type I experimental encephalitis in rats.
D000328:Adult; D000818:Animals; D001812:Blood-Brain Barrier; D002404:Catheterization; D004195:Disease Models, Animal; D004660:Encephalitis / Q000188:drug therapy* / Q000401:mortality; D006566:Herpesviridae Infections / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D066298:In Vitro Techniques; D007274:Injections, Intraperitoneal; D007276:Injections, Intraventricular; D008297:Male; D008826:Microbial Sensitivity Tests; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D010746:Phosphonoacetic Acid / Q000494:pharmacology / Q000627:therapeutic use*; D051381:Rats; D018139:Simplexvirus / Q000187:drug effects / Q000302:isolation & purification; D012882:Skin Tests
D009943:Organophosphorus Compounds; D010746:Phosphonoacetic Acid